NCT02270788 2017-10-03
Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies
St. Jude Children's Research Hospital
Phase 1 Completed
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Arog Pharmaceuticals, Inc.